Vivos Therapeutics, Inc.
VVOS
$0.53
-$0.05-8.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.68M | -6.89M | -5.40M | -5.01M | -3.86M |
| Total Depreciation and Amortization | 454.00K | 442.00K | 384.00K | 306.00K | 177.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 736.00K | -113.00K | 55.00K | 342.00K | 317.00K |
| Change in Net Operating Assets | 482.00K | 2.75M | 799.00K | 871.00K | -426.00K |
| Cash from Operations | -6.01M | -3.81M | -4.16M | -3.49M | -3.80M |
| Capital Expenditure | -18.00K | -1.53M | 83.00K | -771.00K | -122.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -50.00K | 0.00 | -5.14M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.00K | -1.58M | 83.00K | -5.91M | -122.00K |
| Total Debt Issued | 1.40M | 1.45M | -417.00K | 9.64M | -- |
| Total Debt Repaid | -420.00K | -11.00K | -17.00K | -- | -- |
| Issuance of Common Stock | 5.62M | 2.80M | 3.29M | 2.66M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -487.00K | 97.00K | -97.00K | -837.00K | -- |
| Cash from Financing | 6.11M | 4.34M | 2.76M | 11.46M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.00K | -1.06M | -1.32M | 2.06M | -3.92M |